Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies

Kauer, Joseph; Hoerner, Sebastian; Osburg, Lukas; Mueller, Stefanie; Maerklin, Melanie; Heitmann, Jonas S.; Zekri, Latifa; Rammensee, Hans-Georg; Salih, Helmut R.; Jung, Gundram

dc.contributor.author	Kauer, Joseph
dc.contributor.author	Hörner, Sebastian
dc.contributor.author	Osburg, Lukas
dc.contributor.author	Müller, Stefanie
dc.contributor.author	Märklin, Melanie
dc.contributor.author	Heitmann, Jonas S.
dc.contributor.author	Zekri, Latifa
dc.contributor.author	Rammensee, Hans-Georg
dc.contributor.author	Salih, Helmut R.
dc.contributor.author	Jung, Gundram
dc.date.accessioned	2020-11-02T15:11:19Z
dc.date.available	2020-11-02T15:11:19Z
dc.date.issued	2020
dc.identifier.issn	2051-1426
dc.identifier.uri	http://hdl.handle.net/10900/109068
dc.language.iso	en	de_DE
dc.publisher	Bmj Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1136/jitc-2020-000621	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_02090
utue.personen.roh	Kauer, Joseph
utue.personen.roh	Hoerner, Sebastian
utue.personen.roh	Osburg, Lukas
utue.personen.roh	Mueller, Stefanie
utue.personen.roh	Maerklin, Melanie
utue.personen.roh	Heitmann, Jonas S.
utue.personen.roh	Zekri, Latifa
utue.personen.roh	Rammensee, Hans-Georg
utue.personen.roh	Salih, Helmut R.
utue.personen.roh	Jung, Gundram
dcterms.isPartOf.ZSTitelID	Journal For Immunotherapy of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article e000621	de_DE
dcterms.isPartOf.ZS-Volume	8	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE